We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aquestive Therapeutics Inc | NASDAQ:AQST | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.04 | 1.02% | 3.97 | 3.90 | 4.50 | 4.2497 | 3.95 | 4.00 | 2,986,647 | 05:00:05 |
Delaware |
001-38599
|
82-3827296
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which
registered
|
Common Stock, par value $0.001 per share
|
AQST
|
Nasdaq Global Market
|
Item 8.01 |
Other Events.
|
Item 9.01 |
Financial Statements and Exhibits.
|
Exhibit
Number
|
|
Description
|
|
Aquestive Therapeutics Press Release dated January 6, 2023.
|
Dated: January 23, 2023
|
Aquestive Therapeutics, Inc.
|
||
By:
|
/s/ A. Ernest Toth, Jr | ||
Name:
|
A. Ernest Toth, Jr.
|
||
Title:
|
Chief Financial Officer
|
||
(Principal Financial Officer)
|
1 Year Aquestive Therapeutics Chart |
1 Month Aquestive Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions